Effect and safety of landiolol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
- PMID: 22214901
- DOI: 10.1253/circj.cj-11-1454
Effect and safety of landiolol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Comment on
-
Randomized study on the efficacy and safety of landiolol, an ultra-short-acting β1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.Circ J. 2012;76(2):439-45. doi: 10.1253/circj.cj-11-0947. Epub 2011 Dec 10. Circ J. 2012. PMID: 22156314 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
